TENX (Tenax Therapeutics) Accounts Payable: $6.35 Mil (As of Mar. 2026)

What is Tenax Therapeutics Accounts Payable?

Tenax Therapeutics TENX -4.20% 22 Accounts Payable is $6.35 Mil as of Mar. 2026. GuruFocus rates TENX with a GF Score™ of 22/100. The stock has 3 warning signs investors should review.

Tenax Therapeutics's Accounts Payable for the quarter that ended in Mar. 2026 was $6.35 Mil.

Tenax Therapeutics's quarterly Accounts Payable increased from Sep. 2025 ($5.61 Mil) to Dec. 2025 ($6.04 Mil) and increased from Dec. 2025 ($6.04 Mil) to Mar. 2026 ($6.35 Mil).

Tenax Therapeutics's annual Accounts Payable increased from Dec. 2023 ($2.07 Mil) to Dec. 2024 ($3.16 Mil) and increased from Dec. 2024 ($3.16 Mil) to Dec. 2025 ($6.04 Mil).

Tenax Therapeutics Accounts Payable Related Terms

Tenax Therapeutics Accounts Payable Historical Data

* Premium members only.

The historical data trend for Tenax Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tenax Therapeutics Accounts Payable Chart

Tenax Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Accounts Payable

Get a 7-Day Free Trial

0.86

0.45

2.07

3.16

6.04

Tenax Therapeutics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Accounts Payable	Get a 7-Day Free Trial															1.84	0.56	5.61	6.04	6.35

22GF Score

Tenax Therapeutics Inc TENX

Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Tenax Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →

What does a Accounts Payable of $6.35 Mil mean?

Tenax Therapeutics (TENX) has a Accounts Payable of $6.35 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Tenax Therapeutics and its competitors.

Is Tenax Therapeutics' Accounts Payable too high?

Tenax Therapeutics' current Accounts Payable is $6.35 Mil. Overall, Tenax Therapeutics has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.

How does Tenax Therapeutics' Accounts Payable compare to RCKT and AVIR?

Tenax Therapeutics' Accounts Payable of $6.35 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Accounts Payable for a Biotechnology company?

A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Accounts Payable mean?

A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Tenax Therapeutics and its competitors. Tenax Therapeutics's current Accounts Payable is $6.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Tenax Therapeutics stock overvalued right now?

Tenax Therapeutics (TENX) has a current Accounts Payable of $6.35 Mil. The current Accounts Payable is $6.35 Mil. Tenax Therapeutics' overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Accounts Payable calculated?

Accounts Payable is calculated from a company's financial statements. For Tenax Therapeutics (TENX), the current Accounts Payable is $6.35 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tenax Therapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies RCKT AVIR VNDA DMAC OABI PRLD UPB LXEO CYDY PROK VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges YBO0:Germany

Address 101 Glen Lennox Drive, Suite 300, Chapel Hill, NC, USA, 27517

Website https://www.tenaxthera.com

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

22GF Score

Get the complete analysis for TENX

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.55

Price

View TENX Analysis

See Accounts Payable data for all stocks →